#medication_safety
Minoxidil for Hair Loss: What the Evidence Supports
Written by
A 17-study review found oral minoxidil effective and well tolerated for some patients. Here is what to expect, and what to ask a dermatologist. Read more…
Melatonin and Multiple Sclerosis: What a New Review Found
Written by
A 2026 review found melatonin didn’t slow MS. What it may and may not help, and why dose and label accuracy matter. Read more…
Do Longevity Supplements Work? What the Trials Show
Written by
No supplement has been shown to extend human lifespan. Here is what the largest trials found on vitamin D, omega-3s, creatine, NAD+ boosters and multivitamins, and how to use it. Read more…
Glucosamine and Dementia: What the New Study Shows
Written by
A new study linked glucosamine to worse outcomes in people who already have dementia. Here’s what it found, why it isn’t proof, and what to ask your clinician. Read more…
GLP-1 and Muscle: What Protein and Strength Guidance Says
Written by
Part of the weight lost on GLP-1 medications is lean mass. Here is what the trials and clinical advisories say about protein and resistance training, and what to ask your care team. Read more…
BPC-157, the ‘Wolverine’ Peptide: Documented Use Is Rising, but Human Safety Data Is Thin
Written by
Newly confirmed BPC-157 users per quarter rose 33-fold from 2020 to 2026 in one U.S. network’s clinical notes, according to a preprint that has not been peer reviewed. A 2025 review found only three very small human pilot studies. Here’s what the sources show, and what they can’t. Read more…
